NASDAQ:BLUE
bluebird bio Stock News
$1.03
-0.0200 (-1.90%)
At Close: May 17, 2024
Bluebird (BLUE) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Monday, 25'th May 2020
Bluebird (BLUE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
FDA Mishaps Have Investors Asking “What’s Going On With bluebird bio?”
03:10pm, Friday, 22'nd May 2020
Between a string of avoidable problems and instability in the market, bluebird bio might be in for a rough decade.
8 Biotechs Tapping Secondary Markets for $3 Billion
10:53pm, Tuesday, 19'th May 2020
Company stocks drop on dilution, but monies could benefit shareholders down the line Continue reading...
Bluebird Prices New Shares At $55, Seeks To Raise $500 Million
11:19am, Tuesday, 19'th May 2020
Bluebird Bio (BLUE) priced an offering of 9.09 million shares of its common stock at $55 each, the company said late on Monday.The gene therapy company, which expects the offering to close on May 21,
bluebird bio Announces Pricing of Public Offering of Common Stock
01:32am, Tuesday, 19'th May 2020
bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $55.00 per share, before underwri
Bluebird Bio shares are trading lower after the company announced a $400 million common stock offering.
11:19am, Monday, 18'th May 2020Bluebird Bio's stock falls after proposed public stock offering
11:08am, Monday, 18'th May 2020
Shares of Bluebird Bio Inc. fell 2.9% in premarket trading Monday, after the gene therapy company said it was proposing a public offering of $400 million worth of common stock. Based on Friday's stoc
bluebird bio Announces Proposed Public Offering of Common Stock
11:00am, Monday, 18'th May 2020
bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has commenced an underwritten public offering of $400 million of its common stock. bluebird bio also intends to grant the underwriters a 30-da
bluebird (BLUE): Strong Industry, Solid Earnings Estimate Revisions
01:01pm, Friday, 15'th May 2020
bluebird (BLUE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
bluebird bio To Present Data From Gene, Cell Therapy Programs At European Hematology Association Annual Congress On Jun. 12
01:11pm, Thursday, 14'th May 2020
bluebird bio to present data from its gene and cell therapy programs during virtual European Hematology Association Annual Congress.
